WWOX: its genomics, partners, and functions

J Cell Biochem. 2009 Nov 1;108(4):737-45. doi: 10.1002/jcb.22298.


The WW domain-containing oxidoreductase (WWOX) spans one of the most active common fragile sites (CFSs) involved in cancer, FRA16D. WWOX encodes a 46-kDa protein that contains two N-terminal WW domains and a central short-chain dehydrogenase/reductase (SDR) domain. Through its WW domain, Wwox interacts with its partners and modulates their functions. Our data indicate that Wwox suppresses the transactivation function of several transcription factors implied in neoplasia by sequestering them in the cytoplasm. Work from our laboratory and other research groups have demonstrated that Wwox participates in a number of cellular processes including growth, differentiation, apoptosis, and tumor suppression. Targeted deletion of the Wwox gene in mice causes increased spontaneous and chemically induced tumor incidence supporting bona fide tumor suppressor function of WWOX. Moreover, generation of the Wwox-deficient mice uncovers, at least in part, some of the physiological in vivo functions of the WWOX gene. This review focuses on recent progress that elucidates Wwox functions in biology and pathology.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Apoptosis
  • Cell Differentiation
  • Cytoplasm / metabolism
  • Disease Progression
  • Gene Expression Regulation*
  • Humans
  • Mice
  • Models, Genetic
  • Neoplasms / metabolism
  • Oxidoreductases / genetics*
  • Oxidoreductases / physiology*
  • Protein Interaction Mapping
  • Protein Structure, Tertiary
  • Signal Transduction
  • Transcriptional Activation
  • Tumor Suppressor Proteins / genetics*
  • Tumor Suppressor Proteins / physiology*
  • WW Domain-Containing Oxidoreductase


  • Tumor Suppressor Proteins
  • Oxidoreductases
  • WW Domain-Containing Oxidoreductase
  • WWOX protein, human